---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-025873"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2023-05-22T23:59:59+00:00"
generated_at: "2026-06-14T18:09:28.313276+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics to fill Class I director vacancy by Dec 31, 2023 with candidate meeting Nasdaq diversity criteria

## Summary
- After Annual Meeting and re-election of Bryant Fong, a Class I director vacancy will exist.
- Board intends to fill vacancy with a candidate meeting Nasdaq gender diversity criteria.
- Active search for candidate with diversity of skill, experience, gender, race, ethnicity, and age.
- Company aims to fill the vacancy on or before December 31, 2023.

## SEC filing metadata
- accession: 0001140361-23-025873
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2023-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036123025873/0001140361-23-025873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036123025873/brhc20053252_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-025873
- JSON: https://secwatch.observer/filing/0001140361-23-025873.json
- Plain text: https://secwatch.observer/filing/0001140361-23-025873.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.